CIK 0001472012
- Non-accelerated filer
Immunome Inc.
Sign in to watch- Ticker
- IMNM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 770694340
- Phone
- +1 610-321-3700
- Business address
- 18702 N. CREEK PARKWAY, SUITE 100, BOTHELL, WA, 98011
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $334,224
- in 1 filing, $334K under 10b5-1 plans
Net −$334,224. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-06-16 | BARON RICHARD A Director | Grant or award · Stock Option (Right to Buy) | +6,500 | 6,500 | ||
| 2021-09-13 | RAPP MICHAEL Director | Purchase | +25,962 | $19.96 | $518K | 208,742 |
| 2021-09-10 | RAPP MICHAEL Director | Purchase | +15,500 | $17.85 | $277K | 182,780 |
| 2021-09-09 | RAPP MICHAEL Director | Purchase | +8,170 | $17.44 | $142K | 145,000 |
| 2021-09-09 | RAPP MICHAEL Director | Purchase | +22,280 | $18.46 | $411K | 167,280 |
| 2021-08-18 | BARON RICHARD A Director | Exercise or conversion | +2,343 | $11.38 | $27K | 2,343 |
| 2021-08-18 | BARON RICHARD A Director | Exercise or conversion · Stock Option (Right to Buy) | −2,343 | 5,157 | ||
| 2021-06-16 | PRENDERGAST FRANKLYN G Director | Grant or award · Stock Option (Right to Buy) | +7,500 | 7,500 | ||
| 2021-05-28 | WAGENHEIM PHILIP Director | Grant or award · Stock Option (Right to Buy) | +3,750 | 3,750 | ||
| 2021-05-28 | Lefenfeld Michael Director | Grant or award · Stock Option (Right to Buy) | +3,750 | 3,750 | ||
| 2021-05-28 | RAPP MICHAEL Director | Grant or award · Stock Option (Right to Buy) | +3,750 | 3,750 | ||
| 2021-05-28 | LAMATTINA JOHN L Director | Grant or award · Stock Option (Right to Buy) | +3,750 | 3,750 | ||
| 2021-05-28 | BARON RICHARD A Director | Grant or award · Stock Option (Right to Buy) | +3,750 | 3,750 | ||
| 2021-05-28 | Widlitz Michael Director | Grant or award · Stock Option (Right to Buy) | +3,750 | 3,750 | ||
| 2021-05-28 | Roche Corleen M. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +16,609 | 16,609 | ||
| 2021-05-28 | Stoneman Sandra G. General Counsel and CLO | Grant or award · Stock Option (Right to Buy) | +16,609 | 16,609 | ||
| 2021-05-28 | Giesing Dennis H Chief Development Officer | Grant or award · Stock Option (Right to Buy) | +16,609 | 16,609 | ||
| 2021-05-28 | Sarma Purnanand D president and CEO | Grant or award · Stock Option (Right to Buy) | +93,354 | 93,354 | ||
| 2021-05-26 | Lefenfeld Michael Director | Purchase | +1,335 | $19.03 | $25K | 26,872 |
| 2021-05-26 | RAPP MICHAEL Director | Purchase | +2,300 | $18.94 | $44K | 136,830 |
Page 10 of 12 · 240 trades